A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Abbott Laboratories stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 398,509 shares of ABT stock, worth $51.2 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
398,509
Previous 351,018 13.53%
Holding current value
$51.2 Million
Previous $36.5 Million 24.57%
% of portfolio
0.21%
Previous 0.18%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$100.07 - $118.13 $4.75 Million - $5.61 Million
47,491 Added 13.53%
398,509 $45.4 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $543,942 - $607,176
5,400 Added 1.56%
351,018 $36.5 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $1.08 Million - $1.19 Million
9,843 Added 2.93%
345,618 $39.3 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $1.55 Million - $1.89 Million
-17,145 Reduced 4.86%
335,775 $37 Million
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $2.25 Million - $2.7 Million
-23,596 Reduced 6.27%
352,920 $34.2 Million
Q2 2023

Aug 07, 2023

SELL
$100.78 - $112.29 $6.15 Million - $6.85 Million
-61,001 Reduced 13.94%
376,516 $41 Million
Q1 2023

May 11, 2023

SELL
$96.86 - $114.01 $13.6 Million - $16 Million
-139,941 Reduced 24.23%
437,517 $44.3 Million
Q4 2022

Feb 08, 2023

SELL
$95.06 - $111.52 $3.08 Million - $3.61 Million
-32,372 Reduced 5.31%
577,458 $63.4 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $3.35 Million - $3.87 Million
-34,588 Reduced 5.37%
609,830 $59 Million
Q2 2022

Aug 10, 2022

SELL
$102.07 - $123.37 $7.21 Million - $8.72 Million
-70,657 Reduced 9.88%
644,418 $70 Million
Q1 2022

May 11, 2022

BUY
$114.02 - $139.04 $8.32 Million - $10.1 Million
72,936 Added 11.36%
715,075 $84.6 Million
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $1.81 Million - $2.22 Million
-15,694 Reduced 2.39%
642,139 $90.5 Million
Q3 2021

Nov 10, 2021

SELL
$116.66 - $129.06 $367,129 - $406,151
-3,147 Reduced 0.48%
657,833 $77.7 Million
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $16.1 Million - $18.9 Million
-151,938 Reduced 18.69%
660,980 $76.6 Million
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $20.8 Million - $24.5 Million
191,155 Added 30.74%
812,918 $97.4 Million
Q4 2020

Feb 11, 2021

BUY
$105.0 - $114.42 $8.12 Million - $8.85 Million
77,360 Added 14.21%
621,763 $68.1 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $16.4 Million - $19.9 Million
178,544 Added 48.8%
544,403 $59.2 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $261,103 - $334,180
-3,410 Reduced 0.92%
365,859 $33.5 Million
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $966,988 - $1.41 Million
-15,393 Reduced 4.0%
369,269 $29.1 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $768,220 - $855,209
-9,785 Reduced 2.48%
384,662 $33.4 Million
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $6.95 Million - $7.53 Million
84,872 Added 27.42%
394,447 $33 Million
Q2 2019

Aug 09, 2019

BUY
$72.88 - $85.0 $680,043 - $793,135
9,331 Added 3.11%
309,575 $26 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $1.29 Million - $1.56 Million
19,532 Added 6.96%
300,244 $24 Million
Q4 2018

Feb 12, 2019

SELL
$65.56 - $74.27 $751,120 - $850,911
-11,457 Reduced 3.92%
280,712 $20.3 Million
Q3 2018

Nov 05, 2018

SELL
$60.81 - $73.36 $1.09 Million - $1.31 Million
-17,900 Reduced 5.77%
292,169 $21.4 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $6.1 Million - $6.73 Million
105,924 Added 51.89%
310,069 $18.9 Million
Q1 2018

Apr 30, 2018

SELL
$56.27 - $63.62 $6.4 Million - $7.23 Million
-113,712 Reduced 35.77%
204,145 $12.2 Million
Q4 2017

Feb 12, 2018

BUY
$53.68 - $57.47 $899,515 - $963,024
16,757 Added 5.57%
317,857 $18.1 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $360,450 - $402,300
7,500 Added 2.55%
301,100 $16.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
293,600
293,600 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $225B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.